307 filings
Page 5 of 16
6-K
MDWD
MediWound Ltd
7 Jul 22
MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of
7:05am
SC 13D/A
Access Industries Holdings LLC
1 Jul 22
MediWound / Access Industries ownership change
2:34pm
6-K
MDWD
MediWound Ltd
30 Jun 22
MediWound Names Mr. Tzvi Palash as Chief Operating Officer
7:05am
6-K
MDWD
MediWound Ltd
9 Jun 22
Current report (foreign)
7:04am
EFFECT
MDWD
MediWound Ltd
6 Jun 22
Notice of effectiveness
12:15am
CORRESP
MDWD
MediWound Ltd
1 Jun 22
Correspondence with SEC
12:00am
UPLOAD
MDWD
MediWound Ltd
31 May 22
Letter from SEC
12:00am
F-3
MDWD
MediWound Ltd
25 May 22
Shelf registration (foreign)
4:02pm
6-K
MDWD
MediWound Ltd
17 May 22
MediWound Announces CEO Transition
7:06am
6-K
MDWD
MediWound Ltd
17 May 22
MediWound Reports First Quarter 2022 Financial Results
7:05am
6-K
MDWD
MediWound Ltd
12 May 22
MediWound Announces Positive Results from Its U.S. Phase 2 Trial of EscharEx for Debridement of Chronic Wounds
7:04am
6-K
MDWD
MediWound Ltd
22 Mar 22
MediWound Announces Exercise of Over-Allotment Option
4:10pm
SC 13D
MDWD
MediWound Ltd
17 Mar 22
MediWound / Access Industries ownership change
8:47am
20-F
2021 FY
MDWD
MediWound Ltd
Annual report (foreign)
17 Mar 22
7:08am
6-K
MDWD
MediWound Ltd
17 Mar 22
MediWound Reports Fourth Quarter and Full Year 2021 Financial Results
7:05am
424B5
MDWD
MediWound Ltd
3 Mar 22
Prospectus supplement for primary offering
4:45pm
6-K
MDWD
MediWound Ltd
3 Mar 22
MediWound Announces Pricing of Public Offering of Ordinary Shares
4:09pm
424B3
MDWD
MediWound Ltd
2 Mar 22
Prospectus supplement
4:53pm
6-K
MDWD
MediWound Ltd
2 Mar 22
MediWound Ltd. Announces Proposed Public Offering of Ordinary Shares
4:33pm
SC 13G/A
Rosenberg Lior
14 Feb 22
MediWound / ROSENBERG LIOR ownership change
8:00am